The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats

被引:53
作者
Kozan, Ramazan [1 ]
Ayyildiz, Mustafa [1 ]
Agar, Erdal [1 ]
机构
[1] Ondokuz Mayis Univ, Fac Med, Dept Physiol, TR-55139 Samsun, Turkey
关键词
AM251; ACEA; Cannabinoids; Epileptiform activity; Penicillin; PENTYLENETETRAZOLE-INDUCED SEIZURE; CB1 RECEPTOR ANTAGONIST; NEURONAL CULTURE MODEL; CANNABINOID RECEPTOR; ACQUIRED EPILEPSY; MICE; ENDOCANNABINOIDS; CEREBELLUM; GABA; DELTA(9)-TETRAHYDROCANNABIVARIN;
D O I
10.1111/j.1528-1167.2009.02098.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P>Purpose: Several results support the conclusion that the cannabinoid system has a role in generation and cessation of epileptic seizures. The aim of this study was to evaluate the effects of intracerebroventricular AM-251 [N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide], a CB1-receptor antagonist, and ACEA (arachidonyl-2-chloroethylamide), a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats. Methods: In the first set of experiments, 30 min after penicillin injection, AM-251, at doses of 0.125, 0.25, 0.5, and 1 mu g, was administered intracerebroventricularly (i.c.v.). In the second set of experiments, 30 min after penicillin injection, ACEA, at doses of 2.5, 5, 7.5, and 15 mu g (i.c.v.), was administered. In the third set of experiments, AM-251, at doses of 0.125 and 0.25 mu g (i.c.v.), was administered 10 min before ACEA (7.5 mu g, i.c.v.) injection. Results: ACEA, at a dose of 7.5 mu g, significantly decreased the frequency of penicillin-induced epileptiform activity without changing the amplitude. ACEA, at doses of 2.5, 5, and 15 mu g, had no impact on either frequency or amplitude of epileptiform activity. AM-251, at doses of 0.25 and 0.50 mu g, significantly increased the frequency of epileptiform activity. AM-251, at a dose of 0.25 mu g (i.c.v.), was the most effective in changing the frequency of penicillin-induced epileptiform activity, and it also caused status epilepticus-like activity. AM-251, at doses of 0.125 and 0.25 mu g, 10 min before ACEA (7.5 mu g), reversed the anticonvulsant action of ACEA. Discussion: The results of the present study provide electrophysiologic evidence for the role of CB1 receptors in regulating the frequency of epileptiform activity in the model of penicillin-induced epilepsy. To elucidate the precise mechanism of cannabinoid action in the brain during seizure, more advanced electrophysiologic and neurochemical studies are required.
引用
收藏
页码:1760 / 1767
页数:8
相关论文
共 42 条
  • [11] Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy
    Deshpande, Laxmikant S.
    Sombati, Sompong
    Blair, Robert E.
    Carter, Dawn S.
    Martin, Billy R.
    DeLorenzo, Robert J.
    [J]. NEUROSCIENCE LETTERS, 2007, 411 (01) : 11 - 16
  • [12] DICHTER MA, 1994, HARRISONS PRINCIPLES, P2223
  • [13] Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy
    Falenski, K. W.
    Blair, R. E.
    Sim-Selley, L. J.
    Martin, B. R.
    DeLorenzo, R. J.
    [J]. NEUROSCIENCE, 2007, 146 (03) : 1232 - 1244
  • [14] Role of endogenous cannabinoids in synaptic signaling
    Freund, TF
    Katona, I
    Piomelli, D
    [J]. PHYSIOLOGICAL REVIEWS, 2003, 83 (03) : 1017 - 1066
  • [15] Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice
    Gholizadeh, Shervin
    Shafaroodi, Hamed
    GhaseMi, Mehdi
    Bahremand, Arash
    Sharifzadeh, Mohammad
    Dehpour, Ahmad Reza
    [J]. NEUROPHARMACOLOGY, 2007, 53 (06) : 763 - 770
  • [16] Alcohol and marijuana: Effects on epilepsy and use by patients with epilepsy
    Gordon, E
    Devinsky, O
    [J]. EPILEPSIA, 2001, 42 (10) : 1266 - 1272
  • [17] Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents
    Griebel, G
    Stemmelin, J
    Scatton, B
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (03) : 261 - 267
  • [18] Hayase T, 2001, Nihon Arukoru Yakubutsu Igakkai Zasshi, V36, P596
  • [19] Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427
  • [20] Hoffman AF, 2000, J NEUROSCI, V20, P2470